Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Imaging techniques in pancreatic tumors.

D'Onofrio M, Gallotti A, Pozzi Mucelli R.

Expert Rev Med Devices. 2010 Mar;7(2):257-73. doi: 10.1586/erd.09.67. Review.

PMID:
20214430
2.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
3.

Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound.

Schick V, Franzius C, Beyna T, Oei ML, Schnekenburger J, Weckesser M, Domschke W, Schober O, Heindel W, Pohle T, Juergens KU.

Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1775-85. doi: 10.1007/s00259-008-0818-x. Epub 2008 May 15.

PMID:
18481063
4.

Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.

Schmidt GP, Kramer H, Reiser MF, Glaser C.

Top Magn Reson Imaging. 2007 Jun;18(3):193-202. Review.

PMID:
17762383
5.

High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system.

Schmidt GP, Baur-Melnyk A, Herzog P, Schmid R, Tiling R, Schmidt M, Reiser MF, Schoenberg SO.

Invest Radiol. 2005 Dec;40(12):743-53.

PMID:
16304476
6.

Pancreatic cancer: current concepts in imaging for diagnosis and staging.

Tamm E, Charnsangavej C.

Cancer J. 2001 Jul-Aug;7(4):298-311. Review.

PMID:
11561606
7.

18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.

Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.

Ann Surg. 2007 Dec;246(6):932-7; discussion 937-9.

PMID:
18043094
8.

[Non invasive methods in competition for EUS (US, CE-US, CT, MRI and PET/CT): the radiologist point of view].

Martina MC, Cassinis MC, Tappero C, Gandini G.

Minerva Med. 2007 Aug;98(4):343-50. Review. Italian.

PMID:
17921948
10.

Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.

Cantwell CP, Setty BN, Holalkere N, Sahani DV, Fischman AJ, Blake MA.

J Comput Assist Tomogr. 2008 Sep-Oct;32(5):738-44. doi: 10.1097/RCT.0b013e3181591d33.

PMID:
18830103
11.

The value of contrast-enhanced ultrasound in the characterization of vascular pattern of solid pancreatic lesions.

Ardelean M, Sirli R, Sporea I, Bota S, Danila M, Popescu A, Timar B, Buzas R, Mazilu O, Ardelean O, Lighezan D.

Med Ultrason. 2015 Mar;17(1):16-21. doi: 10.11152/mu.2013.2066.171.mars.

12.

Protocol considerations for positron emission tomography-computed tomography of the abdomen and pelvis.

Almusa O, Daly B, Shreve P.

Semin Ultrasound CT MR. 2008 Aug;29(4):251-62.

PMID:
18795492
13.

Recent advances in imaging of pancreatic neoplasms.

Rabinowitz CB, Prabhakar HB, Sahani DV.

Cancer Treat Res. 2008;143:229-54. Review. No abstract available.

PMID:
18619220
14.

Endoscopic evaluation and palliation of pancreatic adenocarcinoma: current and future options.

Pausawasdi N, Scheiman J.

Curr Opin Gastroenterol. 2007 Sep;23(5):515-21. Review.

PMID:
17762557
15.

Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer.

Strobel K, Heinrich S, Bhure U, Soyka J, Veit-Haibach P, Pestalozzi BC, Clavien PA, Hany TF.

J Nucl Med. 2008 Sep;49(9):1408-13. doi: 10.2967/jnumed.108.051466. Epub 2008 Aug 14.

16.

Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice?

Soyka JD, Veit-Haibach P, Strobel K, Breitenstein S, Tschopp A, Mende KA, Lago MP, Hany TF.

J Nucl Med. 2008 Mar;49(3):354-61. doi: 10.2967/jnumed.107.048249. Epub 2008 Feb 20.

17.

[Detection of a neuroendocrine differentiated cystic pancreatic lesion by gallium-68-DOTATOC-PET/CT with inconclusive MRI, CT and ultrasound diagnosis].

Fröling V, Denecke T, Pöllinger A, Schreiter NF.

Rofo. 2010 Feb;182(2):175-7. doi: 10.1055/s-0028-1109828. Epub 2009 Dec 7. German. No abstract available.

PMID:
19998214
18.
19.

Differentiating pancreatic cancer from pseudotumorous chronic pancreatitis.

Yusuf TE, Bhutani MS.

Curr Gastroenterol Rep. 2002 Apr;4(2):135-9. Review.

PMID:
11900678
20.

Cystic pancreatic neoplasms: computed tomography and magnetic resonance imaging findings.

Kehagias D, Smyrniotis V, Gouliamos A, Vlahos L.

Int J Pancreatol. 2000 Dec;28(3):223-30.

PMID:
11373061

Supplemental Content

Support Center